Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced receipt of revised ...
Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...